CINF vs DMAC · P/E 16, rev $11.34B vs $157.4M cap
Cincinnati Financial Corporation (CINF) versus DiaMedica Therapeutics Inc (DMAC) — a side-by-side from cached financials, not a winner call.
Cincinnati Financial Corporation (CINF) is a insurance - property & casualty company listed on US.
DiaMedica Therapeutics Inc (DMAC) is a biotechnology company listed on US.
Latest reported CINF revenue for 2024-12-31 was $11.34B. Net income was $2.29B. Revenue was up 13.2% from 2023-12-31 to 2024-12-31. CINF currently screens at market cap $22.83B and trailing P/E 15.9.
DMAC does not have a complete income-statement cache yet.
CINF currently screens at market cap $22.83B and trailing P/E 15.9. DMAC currently screens at market cap $157.4M.
Not investment advice. Open the CINF and DMAC stock pages for the full models.
Not investment advice.